1911 — China Renaissance Holdings Share News
0.000.00%
Last trade - 00:00- HK$2.08bn
- -HK$1.84bn
- CNY1.20bn
Innovent Biologics rises as regulator approves co's product for cancer treatment
Moves: Jefferies appoints Jason Lam from China Renaissance as Asia TMT investment banking head
Brief: China Renaissance Says Wang Lixing Appointed As CEO
Brief: China Renaissance Hui Yin Ching Appointed As Chairperson
Brief: China Renaissance Says Lam Ka Cheong Jason Resigned As Executive Director
Brief: China Renaissance Announces Disposal Of Convertible Notes
Chinese stocks hit 7-month low，HK shares sink amid deflation fears, Asia weakness
China Renaissance drops most on record as trade resumes after 17-mth halt
China Renaissance shares plunge after 17-month suspension, former chairman's detention (updated)
China Renaissance to open down 71.7% as stock resumes trade after suspension
China Renaissance applies to resume trading from Monday
Brief: China Renaissance Makes Application To Stock Exchange For Resumption Of Trading
Brief: China Renaissance Posts HY Total Revenue RMB328.9 Mln
Brief: China Renaissance To Unwind Think Trader Investment And CR Securities Investment
China's Innovent Biologics jumps to 6-week high on strong Q1 revenue
China's stocks rise for 6th session after big mortgage rate cut
One year on, a star Chinese dealmaker's absence casts pall over his bank
Media: China Renaissance has received buyout interest from firms- Bloomberg News
China picks awkward time to strike fear in markets